The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting
暂无分享,去创建一个
[1] David M. Mosser,et al. Cutting Edge: Biasing Immune Responses by Directing Antigen to Macrophage Fcγ Receptors1 , 2002, The Journal of Immunology.
[2] Giovanni Melioli,et al. Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.
[3] S. Amigorena,et al. Fcγ Receptors and Cross-Presentation in Dendritic Cells , 2002, The Journal of experimental medicine.
[4] C. Bogdan,et al. Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity , 2002, The Journal of experimental medicine.
[5] G. Sanchez-Schmitz,et al. CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells. , 2001, International immunology.
[6] G. Randolph. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. , 2001, Seminars in immunology.
[7] C. Mold,et al. Serum Amyloid P Component Binds to Fcγ Receptors and Opsonizes Particles for Phagocytosis1 , 2001, The Journal of Immunology.
[8] S. Nishikawa,et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. , 2001, International immunology.
[9] Tong-Yuan Yang,et al. Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice , 2001, The Journal of experimental medicine.
[10] A. S. Dagtas,et al. Interleukin‐10 induces macrophage apoptosis and expression of CD16 (FcγRIII) whose engagement blocks the cell death programme and facilitates differentiation , 2001, Immunology.
[11] M. Ernst,et al. Identification of a novel dendritic cell‐like subset of CD64+ / CD16+ blood monocytes , 2001, European journal of immunology.
[12] A. Aderem,et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] I. Maridonneau-Parini,et al. Nonopsonic Phagocytosis of Zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) Involves Distinct Molecular Determinants and Is or Is Not Coupled with NADPH Oxidase Activation , 2000, Infection and Immunity.
[14] L. Weiss,et al. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell‐like characteristics , 2000, European journal of immunology.
[15] T. Di Pucchio,et al. Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice , 2000, The Journal of experimental medicine.
[16] M. Frankenberger,et al. The M-DC8-positive leukocytes are a subpopulation of the CD14+ CD16+ monocytes. , 2000, Immunobiology.
[17] S. Gartner. HIV Infection and Dementia , 2000, Science.
[18] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[19] W. Nockher,et al. CD 14++ Monocytes, CD14+/CD16+ Subset and Soluble CD14 as Biological Markers of Inflammatory Systemic Diseases and Monitoring Immuno-suppressive Therapy , 1999, Clinical chemistry and laboratory medicine.
[20] K. Schäkel,et al. A novel dendritic cell population in human blood: one‐step immunomagnetic isolation by a specific mAb (M‐DC8) and in vitro priming of cytotoxic T lymphocytes , 1998, European journal of immunology.
[21] R. Steinman,et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. , 1998, Science.
[22] R. Steinman,et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] G. Fingerle-Rowson,et al. Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy , 1998, Clinical and experimental immunology.
[24] M. McGrath,et al. Unique monocyte subset in patients with AIDS dementia , 1997, The Lancet.
[25] J. Letterio,et al. A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor β1 Null Mice Is Devoid of Epidermal Langerhans Cells , 1996, The Journal of experimental medicine.
[26] M. Brook,et al. Novel polymer‐grafted starch microparticles for mucosal delivery of vaccines , 1996, Immunology.
[27] Liangji Zhou,et al. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] W. Muller,et al. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. , 1996, Journal of immunology.
[29] G. Randolph,et al. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins , 1996, The Journal of experimental medicine.
[30] H. Ziegler-Heitbrock,et al. Interleukin-10 drives human monocytes to CD16 positive macrophages. , 1996, Journal of inflammation.
[31] J. Ceuppens,et al. Granulocyte-macrophage colony-stimulating factor antagonizes the transforming growth factor-beta-induced expression of Fc gamma RIII (CD16) on human monocytes. , 1996, Immunology.
[32] C. Estcourt,et al. CD14lowCD16high: A cytokine‐producing monocyte subset which expands during human immunodeficiency virus infection , 1995, European journal of immunology.
[33] P. Allavena,et al. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. , 1995, European cytokine network.
[34] E. Jacobs,et al. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. , 1995, Cytometry.
[35] L. Minasian,et al. CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. , 1995, Blood.
[36] P. Lipsky,et al. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. , 1994, Journal of immunology.
[37] F. Sallusto,et al. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.
[38] M. Furie,et al. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro. , 1994, Journal of immunology.
[39] R. Steinman,et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, The Journal of experimental medicine.
[40] L. Davis,et al. Isolation and characterization of human peripheral blood dendritic cells. , 1993, Journal of immunology.
[41] H. Schuurman,et al. Tissue distribution of human IgG Fc receptors CD16, CD32 and CD64: An immunohistochemical study , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[42] W. Muller,et al. Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay , 1992, The Journal of experimental medicine.
[43] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[44] B. Passlick,et al. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. , 1989, Blood.
[45] S. Clarkson,et al. CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes , 1988, The Journal of experimental medicine.
[46] R. van Furth,et al. THE ORIGIN AND KINETICS OF MONONUCLEAR PHAGOCYTES , 1968, The Journal of experimental medicine.